RegInfo: The international database of regulated information of listed companies

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
- Remgro
- RICHEMONT
- RMB Holdings
- Sanlam
- Sasol
- Shoprite
- Standard Bank Group
- Tiger Brands
- Vodacom Group
- WOOLWORTHS
> TA 25
Israel - TA 25
- AVNER OIL
- AZRIELI GROUP
- BEZEQ
- DELEK DRILLIN
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- GAZIT GLOBE
- ICL
- IFF
- ISRAEL CORP
- KENON
- LEUMI
- MIGDAL INSURANCE
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- OSEM
- PAZ OIL
- PERRIGO
- POALIM
- STRAUSS GROUP
- TEVA

Europe

PERIODIC INFORMATION

ANNUAL FINANCIAL REPORT	HALF-YEAR FINANCIAL	QUARTERLY INFORMATION
ABB Ltd ABB Ltd BALOISE	BARRY CALLEBAUT BARRY CALLEBAUT BARRY CALLEBAUT	ADECCO PSP SWISS PROPERTY PSP SWISS PROPERTY
More documents (795)	More documents (604)	More documents (538)
20F	AGM	INTERNAL CONTROL
UBS ABB Ltd NOVARTIS	LAFARGE HOLCIM GAM HOLDING GAM HOLDING	ROCHE LAFARGE HOLCIM LAFARGE HOLCIM
More documents (4)	More documents (87)	More documents (29)
ANNUAL INFO MEMO ART
ARYZTA AG
More documents (1)

PERMANENT INFORMATION

2019.08.16 | 07:00 | Permanent Information Releases / General Company News

ROCHE

FDA approves Roche's RozlytrekTM (entrectinib) for people with ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumours - HTML (w)

2019.08.09 | 21:46 | Permanent Information Releases / General Company News

NOVARTIS

Sandoz will appeal District Court of New Jersey ruling in biosimilar Erelzi® (etanercept-szzs) US patent case - HTML (w)

2019.08.07 | 00:08 | Permanent Information Releases / General Company News

NOVARTIS

Novartis stands behind Zolgensma® (onasemnogene abeparvovec-xioi) for the treatment of children less than 2 years of age with spinal muscular atrophy - HTML (w)

2019.08.05 | 07:00 | Permanent Information Releases / General Company News

ROCHE

Roche's Tecentriq plus platinum-based chemotherapy reduced the risk of disease worsening or death in people with previously untreated advanced bladder cancer - HTML (w)

2019.07.31 | 16:05 | Permanent Information Releases / General Company News

NOVARTIS

Novartis Kisqali significantly prolongs life in women with HR+/HER2- advanced breast cancer now in two distinct Phase III trials - HTML (w)

More documents (3252)

Financial transactions

2019.07.31 | 07:00 | Public offerings / Press Releases during Offer Period

ROCHE

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. - HTML (w)

2019.06.20 | 04:30 | Public offerings / Statement of purchases / sales

LAFARGE HOLCIM

Lafarge S.A. announces results of its tender offer for US$600,000,000 7.125% notes due 2036 - HTML (w)

2019.03.07 | 17:35 | Public offerings / Information note / Note in response

ROCHE

Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in cash - HTML (w)

2018.07.31 | 07:00 | Public offerings / Statement of purchases / sales

ROCHE

Roche Purchases Shares in Tender Offer for FMI - HTML (w)

2018.07.02 | 17:35 | Public offerings / Information note / Note in response

ROCHE

Roche commences tender offer for all shares of Foundation Medicine, Inc. for US$ 137.00 per share in cash - HTML (w)

More documents (38)